Expanding Pharmacists’ Scope of Practice Linked to Improved Cardiovascular Outcomes – APhA submits compounding comments to FDA.

14774_PHARMACY BOARD_072216Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Expanding Pharmacists’ Scope of Practice Linked to Improved Cardiovascular Outcomes – APhA submits compounding comments to FDA. – (866) 348-2889.

Elevating pharmacy involvement in patient care and using a team-based care model are among the effective strategies for preventing cardiovascular disease that were identified in a new guide developed by the Centers for Disease Control and Prevention’s (CDC’s) Division for Heart Disease and Stroke Prevention (DHDSP). The guide, Best Practices for Cardiovascular Disease Prevention Programs: A Guide to Effective Health Care System Interventions and Community Programs Linked to Clinical Services, describes the scientific evidence behind each strategy, including collaborative drug therapy management, enabled by a collaborative practice agreement, and medication therapy management. To be included in the guide, strategies had to be supported by multiple high-quality research studies that demonstrated evidence of effectiveness in controlling blood pressure or cholesterol levels.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.